LR124

Interim study to examine pharmacy benefit manager practices and their impact on prescription drug prices in Nebraska.

This bill proposes an interim study to investigate the role of pharmacy benefit managers (PBM) in Nebraska's health insurance industry and their effect on prescription drug prices. The study will evaluate PBM practices, including contractual relationships, reimbursement models, and formulary management. It will also assess transparency, accountability, and the impact on patient access and independent pharmacies. The Banking, Commerce and Insurance Committee will conduct the study and report findings to the Legislative Council or Legislature.